Title of Invention

PROCESS FOR MAKING AROMATIC NON CONJUGATED ENOL ESTERS OR ENOL ETHERS

Abstract The present invention relates to the field of organic synthesis. More particularly it provides a process for making aromatic non-conjugated enol esters or enol ethers from an aromatic compound or moiety and a protected enal compound or moiety, such as an acetal or an acylal. The reaction is promoted by a salt of formula MX1-4, M representing a transition metal such as Zn or Fe and X representing a mono-anion, or by BY3, wherein Y represents a fluoride or a phenyl group optionally substituted.
Full Text WO 2006/120639 PCT/IB2006/051451
1
CATALYTIC SCRIABINE REACTION
Technical field
The present invention relates to the field of organic synthesis. More particularly it
provides a process for making aromatic non-conjugated enol esters or enol ethers from an
aromatic compound or moiety and a protected enal compound or moiety, such as an acetal
or an acylal. The reaction is promoted by the use of some metal derivatives.
Prior art
The Scriabine reaction consists of the reaction between an aromatic compound and
an enal or the corresponding acylal (see I. Scriabine in Bull. Soc. Chem.Fr., 1961, 1194).
This reaction provides an access to the formation of dihydrocinnamic aldehyde derivatives.
To the best of our knowledge, all the methods and examples reported in the literature
concerning this reaction are at least steochiometric in an Al salt or in TiCl4. For instance
one may cite Aguillar et al. in Synthetic Comm. 2004, 2719.
It is therefore highly desirable to access such dihydrocinnamic aldehyde derivatives
by using a catalyzed reaction, and, if possible, catalysts which are more environmentally
friendly.
Description of the invention
In order to solve the aforementioned problems, the present invention provides a
process for making a compound of the formula

wherein the wavy line indicates that the double bond can be in a configuration E or Z or
a mixture thereof;

WO 2006/120639 PCT/IB2006/051451
2
each R1 represents, taken separately, a hydrogen or halogen atom or a C1-C6 alkyl,
alkoxy or amino group; or the two R1, when taken together, represent a C3-C10
alkanediyl or alkenediyl group optionally substituted and optionally comprising one or
two oxygen, sulfur or nitrogen atoms;
R2 or R3 represents, taken separately, a hydrogen atom or a C1-C6 alkyl group; R2 and
R3, taken together, may represent a C3-C10 alkanediyl or alkenediyl group optionally
substituted;
R4 represents a C1-C7 alkyl or fluorinated alkyl group, a C7-C10 alkylaromatic optionally
substituted, a C1-C7 acyl group, or a -COCOOH or -COCH2COOH group; and
R5 represents a C2-C9 alkanediyl or alkenediyl group optionally substituted;
comprising the coupling of a compound of formula (II) with a compound of formula (III)

wherein R1 to R3 have the meaning indicated in formula (I) and each R6, taken
separately, represents a C1-C7 alkyl or fluorinated alkyl group, a C7-C10 alkylaromatic
optionally substituted, a C1-C7 acyl group, or the R6, taken together, represent a COCO
or COCH2CO group;
or, respectively, the cyclisation of a compound of formula

wherein R1 and R3 have the meaning indicated in formula (I), R6 has the meaning indicated
in formula (III), and R5 has the meaning indicated in formula (I');

WO 2006/120639 PCT/IB2006/051451
3
said processes being characterized in that it is carried out in the presence of a catalytic
amount of at least one catalyst selected from the group consisting of
- a salt of formula MXn, M representing a transition metal selected from the group
consisting of Fe, Co, Ni, Cu and Zn, X representing a mono-anion and n is an integer
from 1 to 3; and
- a boron compound of formula BY3, wherein Y represents a fluoride or a phenyl group
optionally substituted, and anyone of its adducts with a C2-C10 ether or a C1-C8
carboxylic acid.
Possible substituents of R1 to R6 are one, two or three halogen atoms or ORa, NRa2
or R.a groups, in which Ra is a hydrogen atom or a C1 to C10 cyclic, linear or branched alkyl
or alkenyl group, preferably a C1 to C4 linear or branched alkyl or alkenyl group.
Possible substituents of Y are one to five groups such as halide atoms or methyl or
CF3 groups.
It is also understood that, when R1 are not hydrogen atoms, the compound of
formula (I), or (I'), can be in the form of a mixture of isomers. For example, if the
compound of formula (II) is methyl-benzene, then the compound (I) obtained can be in the
form of a mixture of the ortho, or meta, and para isomers.
According to a first embodiment of the invention, the invention provides a process
for making a compound of formula (I) or (I') wherein R4 represents a C1-C7 alkyl group, a
benzyl group optionally substituted or a C1-C7 acyl group.
According to a further embodiment, R2 or R3 may represent, taken separately, a
hydrogen atom or a C1-C4 alkyl group; R2 and R3, taken together, may represent a C3, C4
or C10 alkanediyl or alkenediyl group optionally substituted.
Moreover, each R1 may represent, taken separately, a hydrogen or halogen atom or
a C1-C4 alkyl or alkoxy group; or the two R1, when taken together, represent a C3-C5
alkanediyl or alkenediyl group optionally substituted and optionally comprising one or two
oxygen, sulfur or nitrogen atoms. According to a further embodiment, one, or the two, R1
are not a hydrogen atom.
Furthermore, R3 may also represent a C2-C3 alkanediyl or alkenediyl group
optionally substituted.
It is understood that in such embodiment the starting material are the

WO 2006/120639 PCT/IB2006/051451
4
corresponding compounds of formula (II) and (III), or the corresponding compound of
formula (IV).
According to a further embodiment of the present invention the invention provides
a process for making a compound of formula (I) by the reaction of a compound of
formula (II) with a compound of formula (III).
As non limiting examples of compound of formula (II) one may cite the following:
benzene optionally substituted by one or two C1-C4 alkyl groups, 1,3-benzodioxole or
indane optionally substituted by one or two C1-C4 alkyl groups, and in particular 1,1-
dimethyl indane.
As non limiting examples of compound of formula (III) one may cite the following:
acrolein diethyl acetal, acrolein diacetate, methacrolein diacetate, crotonaldehyde
diacetate, tiglyl diacetate, cyclohexenyl carbaldehyde diacetate.
As mentioned above the invention process is carried out in the presence of at least
one catalyst which is a salt of formula MXn or a compound of formula BY3 and adducts
thereof. Said catalyst can be in the anhydrous form or also in the hydrate form, except for
those acids which are unstable in the presence of water. However the anhydrous form is
preferred.
Furthermore, according to a particular embodiment of the invention the use of only
one compound of formula MXn as catalysts is also preferred.
According to a particular embodiment of the invention, the catalyst is selected from
the group consisting of BY3 and adducts thereof, FeX3, CoX2, NiX2, ZnX2, CuX2 and
CuX.
According to a particular embodiment of the invention, the catalyst is selected from
the group consisting of BY3 and its adducts above mentioned. FeX3. NiX2. ZnX2: and
CuX2 are particularly useful. Yet, more particularly, the catalyst may be a selected
amongst BY3 and its adducts above mentioned, FeX3, and ZnX2.
As mentioned above BY3 can be used alone or in the form of one of its adducts
with an ether or a carboxylic acid Specific examples are the adducts of BF3 with Et2O,
Bu2O or AcOH.
According to another embodiment of the invention, X is a mono-anion selected
from the group consisting of acetylacetonate optionally substituted, Cl-, Br-, C1-9

WO 2006/120639 PCT/IB2006/051451
5
carboxylate, a C1-10 sulphonate, ClO4-, BF4-, PF6-, SbCl6-, AsCl6-, SbF6-, AsF6-, BR74-,
wherein R7 is a phenyl group optionally substituted by one to five groups such as halide
atoms or methyl or CF3 groups, or a R8SO3-, wherein R8 is a chlorine or fluoride atom. In
particular X can be selected from the group consisting of Cl-, Br- and
trifluoromethylsulfonate.
According to another embodiment of the invention, Y is F or C6H5.
According to a further embodiment of the invention, the catalyst is BF3 and its
adducts with AcOH, FeCl3, ZnBr2 or ZnCl2.
The catalyst can be added to the reaction medium in a large range of
concentrations. As non-limiting examples, one can cite catalyst concentrations ranging
from 0.001 to 0.30 molar equivalents, relative to the molar amount of the starting
compound (II) or (IV). Preferably, the catalyst concentrations will be comprised between
0.005 and 0.15 molar equivalents. It goes without saying that the optimum concentration
of catalyst will depend on the nature of the catalyst and on the desired reaction time.
One can also cite catalyst concentrations ranging from 0.1 to 0.30 molar
equivalents, relative to the molar amount of the starting compound (III). Preferably, the
catalyst concentrations will be comprised between 0.01 and 0.10 molar equivalents. It goes
without saying that the optimum concentration of catalyst will depend on the nature of the
catalyst and on the desired reaction time.
It is useful here to mention that by "catalytic amount' we mean here any amount
which allow the formation of the desired compound with a molar yield which exceeds the
molar equivalents of catalyst added to the reaction mixture.
The temperature at which the invention's process can be carried out is typically
between 0°C and 180°C, more preferably in the range of between 15°C and 100°C. Of
course, a person skilled in the art is also able to select the preferred temperature as a
function of the melting and boiling point of the starting and final products. Of course, a
person skilled in the art is also able to select the preferred temperature as a function of the
melting and boiling point of the starting and final products as well as of the solvent.
The process of the invention can be carried out in the presence or in the absence of
solvent. As a person skilled in the art can anticipate, the presence of a solvent is mandatory

WO 2006/120639 PCT/IB2006/051451
6
only in the case in which the starting compound is a solid compound under the reaction
conditions.
However, according to a preferred embodiment of the invention, and independently
of the physical state of the starting compound, the process is advantageously carried out in
the presence of a solvent. Preferably, said solvent is anhydrous or does not contain more
than 1% w/w water.
Non-limiting examples of such a solvent are C4-C8 ethers, C3-C6 esters, C3-C6
amides, C6-C9 aromatic solvents, C5-C7 linear or branched or cyclic hydrocarbons, C1-C2
chlorinated solvents and mixtures thereof.
Furthermore, the reaction can also be carried out in the presence of a solvent
belonging to the family of carboxylic anhydride of formula R9C(O)O(O)CR9, R9
representing a C1-C7 alkyl group, a C7-C10 alkylaromatic optionally substituted, a C1-C7
acyl group, optionally containing the corresponding carboxylic acid R9COOH. The
optional substituents being the same as for R6.
The compound of formula (III) or (IV) can be made and isolated according to any
prior art method. Alternatively, compound (III) or (IV) can be also generated in situ, i.e.
in the reaction medium just before its use, according to any know prior art method.
In particular, preferably the compound of formula (III) or (IV) is made or
generated by a method using the corresponding enal as starting material.
Therefore, another object of the present invention is an invention's process, as
defined above, further comprising the step of generating in situ the compound of
formula (III) or (IV) starting from the corresponding enal of formula (V) or (V)
respectively

wherein R1, R2, R3 and R5 have the same meaning indicated above.

WO 2006/120639 PCT/IB2006/051451
7
A process comprising the in situ generation of the compound of formula (III) or
(I') is particularly useful when said compound (III) or (I') is an acetal or an acylal, the
latter being a geminal dicarboxylate.
Now, when the compound of formula (II) is an acylal, we have also noticed that
the catalysts that are able to promote the cyclisation of the acylal are also useful to
promote the conversion of the enal into the corresponding acylal.
Therefore, another object of the present invention, and in fact a particular
embodiment of the above-mentioned process, is a process for making a compound of
formula (I) or (I'), as defined above, comprising the step of reacting, in the presence of a
catalyst as defined above, an enal of formula (V) or (V'), as defined above, with a
carboxylic anhydride of formula R9C(O)O(O)CR9, wherein R9 has the meaning indicated
above.
The invention will now be described in further detail by way of the following
examples, wherein the abbreviations have the usual meaning in the art, the temperatures
are indicated in degrees centigrade (°C). The NMR spectral data were recorded in CDCl3
at 400MHz or 100MHz for 1H or 13C, respectively, the chemical displacements 8 are
indicated in ppm with respect to TMS as standard, and the coupling constants J are
expressed in Hz. All the abbreviations have the usual meaning in the art. Each NMR
spectra is provided in respect of the mayor isomer obtained, unless differently specified.
Example 1
Reaction between acrolein diacetate and 2-methyl indane
A solution of FeCl3,6H2O in acetic acid (1.0M 1.0ml, 1 mmol) was added slowly
dropwise to acetic anhydride (20.4 g, 200 mmol) at 5°C. The solution was allowed to
warm to room temperature. A solution of acrolein (5.6 g, 100 mmol), in 2-methyl indane
(20.0 g, 151 mmol) and dichloromethane (15 g) was added slowly dropwise to the
anhydride solution, maintaining the temperature at about 15°C. The mixture was stirred at
20°C for 4 hours then diluted with ethyl acetate (150 ml), and a saturated aqueous
NaHCO3 solution (50 ml) was added slowly dropwise. The aqueous phase was re-
extracted with ethyl acetate (150 ml). The combined organic phases were washed with

WO 2006/120639 PCT/IB2006/051451
8
saturated aqueous NaHCO3 solution (100 ml), brine (100 ml), dried over MgSO4 and the
solvents removed in vacuo. Further purification by KugelRohr distillation at 150°C (2.9 x
10-1 mbar) gave the desired enol acetate as a mixture of isomers (7.2 g, 30%).
1H-NMR: 1.13 (d, J 6.2, 3H), 2.11 (s, 3H), 2.43-2.59 (m, 3H), 2.98-3.06 (m, 2H), 3.29 (d,
J 8.2, 2H), 5.53-5.60 (m, 1H), 6.95 (d, J 7.2, 1H), 7.02 (s, 1H), 7.10 (d, J 7.7, 1H),
7.18 (dt, J 13.8,1, 1H).
13C-NMR: 20.7 (q), 20.9 (q), 33.5 (t), 34.65 (d), 40.7 (t), 41.0 (t), 114.2 (d), 124.4 (d),
126.0 (d), 136.0 (d), 137.5 (s), 141.8 (s), 144.2 (s), 168.2 (s).
Example 2
Reaction between acrolein diacetate and 2-methyl indane
A suspension of 2-methyl indane (2.6 g, 20 mmol) and acrolein diacetate (1.6 g, 10 mmol)
and zinc bromide (0.25 g, 1 mmol) was stirred for 24 hours at ambient temperature. The
reaction medium was then diluted with ethyl acetate (50 ml), and a saturated aqueous
NaHCO3 solution (50 ml) was added slowly dropwise. The aqueous phase was re-
extracted with ethyl acetate (50 ml). The combined organic extracts were washed with
saturated aqueous NaHCO3 solution (50 ml), brine (50 ml), dried over MgSO4. filtered and
the solvents removed in vacuo. Further purification of the residue by KugelRohr
distillation 180°C (8.0 x 10-1 mbar) gave the enol acetate as a mixture of isomers (0.65 g,
30%) identical to that prepared above.
Example 3
Reaction between 2.2 dimethyl dihvdrobenzofuran and acrolein diacetate
Zinc bromide (50 mg, 0.2 mmol) was suspended in a solution of acrolein diacetate (1.6 g,
10 mmol), 2,2 dimethyl dihydrobenzofuran (1.5 g, 10 mmol), in dichloromethane (5 g) and
the stirred at ambient temperature for 24 hours. The reaction medium was then diluted
with ethyl acetate (25 ml) and the saturated aqueous NaHCO3 solution (20 ml) was added
slowly dropwise. The aqueous phase was re-extracted with ethyl acetate (25 ml). The
combined organic phase was washed with saturated aqueous NaHCO3 solution (25 ml),
brine (25 ml), then dried over MgSO4, filtered and the solvents removed in vacuo. Further

WO 2006/120639 PCT/IB2006/051451
9
purification by KugelRohr distillation 160°C (3.3 x 10-1 mbar) gave the desired enol acetate
as a mixture of isomers (0.9 g, 37%).
1H-NMR: 1.45 (s, 6H), 2.11 (s, 3H), 2.97 (s, 2H), 3.25 (d, J 7.7, 2H), 5.55 (dt, 12.3, 7.7,
1H), 6.64 (d, 8.2, 1H), 6.91 (d, J 8.2, 1H), 6.96 (s, 1H), 7.16 (d, 12.3, 1H).
13C-NMR: 20.7 (q), 28.3 (q), 33.0 (t), 42.9 (t), 86.6 (s), 109.2 (d), 114.5 (d), 125.1 (d),
127.4 (s), 127.8 (d), 131.2 (s), 136.0 (d), 157.5 (s), 168.2 (s).
Example 4
Reaction between 2-methylindane and methacrolein diacetate
BF3 acetic acid complex (0.2 g, 1 mmol) was added to a stirred solution of 2-methyl
indane (13.2 g, 100 mmol) and methacrolein diacetate (8.7 g, 50 mmol) heated at 60°C.
The mixture was stirred at 60°C for one hour, then cooled and diluted with ethyl acetate
(50 ml), and saturated aqueous NaHCO3 solution (50 ml) was added slowly dropwise. The
aqueous phase was re-extracted with ethyl acetate (50 ml), the combined organic phase
was washed with NaHCO3 (100 ml), dried over MgSO4, filtered and the solvents removed
in vacuo. The residue was further purified by KugelRohr distillation 160°C (6.0 x 10-1
mbar) to give the enol acetate as a mixture of isomers (2.3 g, 19%).
1H-NMR: (major isomer only) 1.13 (d, J 6.7, 3H), 1.60 (d, J 1.5, 3H), 2.14 (s, 3H), 2.44-
2.59 (m, 3H), 2.97-3.05 (m, 2H), 3.22 (s, 2H), 6.93 (d, J 6.7, 1H), 6.99 (s, 1H), 7.05
(d,J1.5,lH), 7.08 (d, J 7.2, 1H).
13C-NMR: 13.6 (q), 20.8 (q), 20.7 (q), 34.7 (d), 40.2 (t), 40.8 (t), 41.1 (t), 121.6 (s),
124.2 (d), 124.8 (d), 126.6 (d), 131.1 (d), 136.8 (s), 141.8 (s), 144.1 (s), 168.3 (s).
Example 5
Reaction between an aromatic and acroleine diacetate
A) General procedure
A solution of FeCl3.6H2O in acetic acid (1.0M, 2-3 ml, 2-3 mmol, 5-10% mol) was added
to a stirred solution of the indane derivative (35 mmol) acetic anhydride (2 g) and acrolein
diacetate (6.5 g, 41 mmol) cooled to 0°C. Stirred for a further 60 minutes at ambient
temperature, diluted with ethyl acetate (50 ml), and added saturated sodium bicarbonate

WO 2006/120639 PCT/IB2006/051451
10
(25 ml) slowly dropwise. The aqueous phase was re-extracted with ethyl acetate (50 ml),
the combined organic phase was washed with bicarbonate (50 ml) then brine (50 ml), dried
over magnesium sulfate, filtered and the solvents removed in vacuo. The crude product
was purified by Kugelrohr distillation, firstly under moderate vacuum (5-10 mbar) to
recover the indane, then under high vacuum (1.0-4.0 x 10-1 mbar).
2-ethylindane
yield (18%), b.p 160°C at 2.8 x 10-1 mbar
1H-NMR: 0.96 (t, J 7.2, 3H), 1.50 (quintet, J 7.2, 2H), 2.10 (s, 3H), 2.34 (septet, J 7.2,
2H), 2.60-2.46 (m, 2H), 2.95-3.05 (m, 2H), 3.28 (d, J 7.7, 2H), 5.51-5.60 (m, 1H),
6.94 (d, J 7.7, IH), 7.01 (s, IH), 7.09 (d, J 7.7, IH) 7.17 (dt, J 12.3, 1.5, 1H)
13C-NMR: 12.8 (q), 20.7 (q), 28.7 (t), 33.5 (t), 38.6 (t), 38.9 (t), 42.2 (d), 114.3 (d),
124.4 (d), 126.1 (d), 136.1 (d), 137.6 (s), 141.8 (s), 144.2 (s), 168.2.
2-propyl indane
yield 1.4 g, 18%, b.p 150°C at 2.5 x l0-1 mbar)
1H-NMR: 0.88-0.95 (m, 3H), 1.36-1.51 (m, 4H), 2.14 (s, 3H), 2.41-2.59 (m, 2H), 2.95-
3.05 (m, 2H), 3.28 (d, J 7.7, 2H), 5.56 (dt, J 12.8,7.2, 1H), 6.94 (d, J 7.7, 1H), 7.01
(s, 1H), 7.08-7.19 (m,2H).
I3C-NMR: 14.3 (q), 20.7 (q), 21.5 (t), 33.5 (t), 38.1 (t), 38.9 (t), 40.20 (d), 114.3 (d),
124.4 (d), 126.0 (d), 126.1 (d), 136.1 (d), 137.5 (s), 141.8 (s), 143.7 (s), 144.2 (s),
168.2 (s).
2,2 dimethyl indane
purified by column chromatography over silica (200 ml) with ether:pentane as eluant (1:19
then 1:9) gave the desired enol acetate (1.1 g, 14%).
1H-NMR: 1.13 (s, 6H), 2.11 (s, 3H), 2.65-2.73 (m, 4H), 3.28 (d, J 7.7, 2H), 5.50-5.60 (m,
1H), 6.94 (d, J 7.7, 1H), 6.98 (s, 1H), 7.07 (d, J 7.7, 1H), 7.18 (dt, J 10.8, 1.5, 1H).
13C-NMR: 20.8 (q), 28.8 (q), 33.5 (t), 40.2 (s), 47.4 (t), 47.7 (t), 114.3 (d), 124.7 (d),
126.0 (d), 136.1 (d), 137.5 (s), 141.6 (s), 144.0 (s), 168.2 (s).
cis trans 1,2 dimethyl indane

WO 2006/120639 PCT/IB2006/051451
11
yield 1.7 g, 28%, b.p 150°C at 4.5 x 10-1 mbar.
1H-NMR: 0.94-1.08 (m, 3H), 1.10-1.14 (m, 3H), 1.16-1.20 (m, 1H), 1.25-1.29 (m, 1H),
2.11 (s, 3H), 2.47-2.58 (m, 3H), 2.90-2.99 (m, 2H), 3.12 (septet, J 6.7, 1H), 3.30 (t,
J6.2, 2H), 5.55-5.59 (m, 1H), 6.94-7.20 (m, 4H).
I3C-NMR: 14.7 (q), 15.2 (q), 20.8 (q), 33.6 (t), 38.0 (d), 39.4 (t), 39.8 (t), 42.0 (d), 42.4
(d), 114.2 (d), 123.6 (d), 124.4 (d), 126.1 (d), 126.2 (d), 134.4 (s), 136.1 (d), 141.0
(s), 149.3 (s), 168.2 (s).
B) Tetrahydronapthalene
A solution of FeCl3.6H2O (1.0M in acetic acid, 1.0 ml, 1 mmol) was added to stirred
solution of 1,2,3,4 tetrahydronaphthalene (21.65 g, 164 mmol), acetic anhydride (1.4 g,
13.6 mmol), acrolein diacetate (5.4 g, 34 mmol). The solution was stirred for a further 3
hours at ambient temperature, then poured into 5% sodium bicarbonate solution (200 ml),
then the aqueous phase was extracted with ether (200 ml). The organic phase was washed
with brine, dried over sodium sulfate, filtered and the solvents removed in vacuo. The
residue was further purified by column chromatography on silica (300 ml) with
cylohexane:ethyl acetate 19:1 and gave the enol acetates as a mixture of regio isomers (a
and (3 (major) naphthyl, plus E and Z).
1H NMR (both isomers): 1.70-1.86 (m, 4H), 2.11 (s, 3H), 2.64-2.80 (m, 4H), 3.21-3.29
(m, 2H), 5.55 (dt, J 12,7, 1H), 6.82-7.25 (m, 4H).
13C NMR(both isomers): 20.7 (q), 22.8 (t), 23.2 (t), 23.3 (t), 23.4 (t), 26.2 (t), 29.2 (t),
29.6 (t), 30.3 (t), 30.8 (t), 33.4 (t), 113.9 (d), 114.7 (d), 126.2 (d), 126.3 (d), 126.8
(d), 128.5 (d), 128.8 (d), 130.1 (d), 135.9 (s), 136.0 (s), 136.9 (d), 137.2 (d), 137.6
(s), 138.1 (s), 138.4 (d), 138.6 (d), 168.2 (s).
C) 1.1 Dimethyl indane
A solution of FeCl3.6H2O (1M in acetic acid, 0.3 ml) was added slowly drop wise to a
stirred solution of 1,1 dimethyl indane (4.1 g, 28 mmol) acrolein diacetate (1.1 g, 7 mmol)
and acetic anhydride (0.3 g, 2.8 mmol). After 2 hours stirring at room temperature, the
mixture was poured into brine (50 ml) and the aqueous phase extracted with ether
(100 ml). The organic phase was washed with sodium bicarbonate (50 ml), then brine

WO 2006/120639 PCT/IB2006/051451
12
(50 ml), dried over magnesium sulfete, filtered and the solvents removed in vacuo. The
residue was further purified by Kugelrohr distillation, 120°C at l0mbar gave recovered
1,1 dimethyl indane (2.2 g) then distillation at 160°C at 0.3 mbar gave the enol acetates as
a mixture of isomers, (1.2 g, yield: 70%).
1H NMR: 1.25 (s, 6H), 1.91 (t, J 7, 2H), 2.11 (s, 3H), 2.84 (t, J 7, 2H), 3.32 (d, J 7, 2H),
5.58 (dt, J 12, 7, 1H), 6.95 (s, 1H), 6.96 (d, J 8, 1H), 7.10 (d, J 8, 1H), 7.18 (dt, J 12,
8, 1H).
13 NMR: 20.7 (q), 28.6 (q), 29.6 (q), 33.6 (t), 41.6 (t), 43.9 (t), 114.2 (d), 121.9 (d), 124.4
(d), 126.3 (d), 136.1 (d), 137.8 (s), 140.8 (s), 153.0 (s),168.1 (s)
Example 6
Reaction between Tert-butyl benzene and acrolein diacetate
A solution of FeCl3.6H2O (1M in acetic acid, 2.5 ml, 2.5 mmol) was added slowly drop
wise to a stirred solution of tert-butyl benzene (55 g, 410 mmol) acrolein diacetate (13.5 g,
85 mmol) and acetic anhydride (3.5 g, 34.3 mmol). After 3 hours stirring at room
temperature, the mixture was poured into brine (50 ml) and the aqueous phase extracted
with ether (2 x 100 ml). The organic phase was washed with sodium bicarbonate (50 ml),
then brine (50 ml), dried over magnesium sulfate, filtered and the solvents removed in
vacuo. The residue was further purified by column chromatography on silica (500 ml) with
cyclohexane then 5:95 ethyl acetate:cyclohexane gave recovered tert-butyl benzene then
the enol acetates as a mixture of meta and para isomers, (2.7 g, yield: 14%).
1H NMR: (both isomers) 1.31 (s, 9H), 2.11 (s, 3H), 3.30 (d, J 8, 2H) 5.58 (dt, J 12, 8, 1H),
7.12-7.21 (m, 4H), 7.32 (d, J 8, 1H).
1NMR: 20.7 (q), 30.1 (s), 31.4 (q), 33.0 (t), 34.4 (s), 112.6 (d), 113.9 (d), 125.4 (d),
127.9 (d), 128.0 (d), 134.5 (d), 136.2 (d), 136.7 (d), 136.9 (d), 149.0 (s), 149.2 (s),
168.0 (s), 168.2 (s).
Example 7
Reaction between Sec-butyl benzene and acrolein diacetate
A solution of FeCl3.6H2O (1M in acetic acid, 0.5 ml, 0.5 mmol) was added slowly drop

WO 2006/120639 PCT/IB2006/051451
13
wise to a stirred solution of sec-butyl benzene (11 g, 82 mmol) acrolein diacetate (2.7 g,
17mmol) and acetic anhydride (0.7 g, 6.8 mmol) in dichloromethane (15 ml). After 3
hours stirring at room temperature, the mixture was poured into saturated sodium
bicarbonate (50 ml) and the aqueous phase extracted with ether (100 ml). The organic
phase was washed with saturated sodium bicarbonate (50 ml), then brine (50 ml), dried
over magnesium sulfate, filtered and the solvents removed in vacuo. The residue was
further purified by column chromatography on silica (500 ml) with cyclohexane then 5:95
ethyl acetate:cyclohexane gave recovered sec-butyl benzene then the enol acetate as a
mixture of isomers, (1.3 g, yield: 33%).
1H NMR: 0.81 (t, J 7, 3H), 1.21 (d, J 7, 3H), 1.57 (q, J 7, 2H), 2.11 (s, 3H), 2.57 (s, J7,
1H), 3.30 (dd, J 8,1,2H), 5.65-5.52 (m, 1H), 7.10-7.25 (m, 5H).
13 NMR: 12.2 (q), 20.7 (q), 21.8 (q), 31.2 (t), 33.19 (t), 41.3 (d), 114.0 (d), 127.2 (d),
128.2 (d), 136.2 (d), 137.0 (s), 168.2 (s).
Example 8
Reaction between 1,3 benzodioxole and methacrolein diacetate
Zinc chloride (0.14 g, 1 mmol, 10mol%) was added to a stirred solution of 1,3
methylenedioxy benzene (2.4 g, 20 mmol) and methacrolein diacetate (1.72 g, 10 mmol) at
ambient temperature. The solution was stirred at ambient temperature for a further 48
hours. The solution was diluted with ethyl acetate (59 ml), and sodium bicarbonate 5%
(50 ml), the aqueous phase was re-extracted with ethyl acetate (50 ml), the organic phase
was washed with brine (50 ml), dried over magnesium sulfate, filtered and the solvents
removed in vacuo The residue was further purified by column chromatography over silica
(50 ml), with cylohexane then 1:19 then 1:9 ethyl acetatexylohexane as eluant. The
desired product 1.23 g was further purified by Kugelrohr distillation 125°C at 3.5 x 10-2
mbar, to give the enol acetate, (1.0 g, yield: 53%).
1H NMR: 1.58 (d, J 1.5, 3H), 2.14 (s, 3H), 3.17 (s, 2H), 5.91 (s, 2H), 6.63 (dd, J 8, 1.5,
1H), 6.67 (d, J 1.5, 1H), 6.72 (d, J 8, 1H), 7.02 (d, J 1.5, 1H).
13 NMR: 13.4 (q), 20.8 (q), 40.0 t), 100.9 (t), 108.0 (d), 109.0 (d), 121.3 (s), 121.7 (d)
131.2 (d), 132.8 (s), 146.1 (s), 147.7 (s) and 168.3 (s).

WO 2006/120639 PCT/IB2006/051451
14
Example 9
Reaction between anisole and tiglic diacetate
Zinc chloride (0.14 g, 1 mmol), was added to a solution of anisole (2.16 g, 20 mmol) and
tiglic diacetate (1.86 g, 10 mmol), and the mixture stirred at ambient temperature for 3
hours. The solution was diluted with ethyl acetate (25 ml) and saturated sodium
bicarbonate (50 ml), the aqueous phase was re-extracted with ethyl acetate (25 ml) the
combined organic phases were washed with brine, dried over magnesium sulfate, filtered
and the solvents removed in vacuo. Further purification by column chromatography over
silica (50 ml) with cyclohexane, then 1:19, then 1:9 ethyl acetate cyclohexane gave the
enol acetate as a mixture of isomers. Further purification by Kugelrohr distillation 125°C
at 3.5 x 10-2 mbar gave the enol acetate as a mixture of isomers, (1.2 g, yield: 51%).
1HNMR: 1.37 (d, J 7, 3H), 1.51 (d 1.5, 3H), 2.13 (s, 3H), 3.37 (q, J 7, 1H), 3.77 (s, 3H),
6.83 (d, J 9, 2H), 7.13 (d, J 9, 2H), 7.13 (m, 1H).
13C NMR: 12.1 (q), 19.3 (q), 20.8 (q), 42.5 (d), 55.2 (q), 113.6 (d), 128.3 (d), 130.6 (d),
136.2 (s), 158.0 (s), 168.3 (s).
Example 10
Reaction between 2-methyl indane and crotonaldehyde diacetate
Acetic anhydride (5 g, 49 mmol) was added to a suspension of FeCl3.6H2O (1.08 g.
4 mmol) and 2-methyl indane (26.4 g, 200 mmol), after 5 mins crotonaldehyde diacetate
(6.88 g, 40 mmol) was added slowly drop wise. The mixture was stirred for a further 7
hours, then poured into brine (50 ml), extracted with ether (100 ml), washed the organic
extract with sodium bicarbonate (100 mi), then brine (50 mi), dried over magnesium
sulfate, filtered and the solvents removed in vacuo. The residue was further purified by
distillation, 65°C at 10 mbar, gave the recovered 2-methyl indane then distillation of the
residue 170°C at 0.1 mbar gave the enol acetate as a mixture of isomers, (4.3 g, yield:
44%).
1H NMR (for both major isomers): 1.11-1.17 (m, 3H), 1.34 (d, J 7, 3/2H), 1.36 (d,J 6.6,
3/2H) 2.07 (s: 3/3H), 2.09 (s, 3/3H), 2.15 (s, 3/3H), 2.45-2.58 (m, 3H), 2.96-3.08
(m, 2H), 3.45 (quintet, J 7, 1/2H), 3.96 (m, 1/2H), 5.03 (dd, J 10, 7, 1/2H), 5.61 (dd,

WO 2006/120639 PCT/IB2006/051451
15
J 12.8, 7, 1/2H), 6.94-7.20 (m, 4H).
13C NMR(for both major isomers): 20.7 (q), 20.9 (q), 22.0 (q), 34.5 (d), 34.8 (d), 40.8 (t),
41.1 (t), 119.3 (d), 123.0 (d), 124.4 (d), 124.8 (d), 126.0 (d), 132.6 (d), 135.0 (d),
141.9 (s), 143.5 (s), 144.2 (d), 168.7 (s).
Example 11
Reaction between anisole and cyclohexenyl carbaldehyde diacetate
A solution of FeCl3.6H2O (1M in acetic acid, 0.31 ml) was added slowly dropwise to a
stirred solution of anisole (5.53 g, 51 mmol) cyclohexane carbaldehyde diacetate (2.3 g,
10.8 mmol) and acetic anhydride (0.46 g, 4.5 mmol). After 4 hours stirring at room
temperature, the mixture was poured into brine (50 ml) and the aqueous phase extracted
with ether (2 x 100 ml). The organic phase was washed with sodium bicarbonate (50 ml),
then brine (50 ml), dried over magnesium sulfate, filtered and the solvents removed in
vacuo. The residue was further purified by column chromatography on silica (500 ml) with
cyclohexane then 5:95 ethyl acetate xyclohexane gave the enol acetates as a mixture of
isomers, (2.57 g, 91%).
MS: M(+) 260, 200,172, 169, 121, 108, 43 m/z.
Example 12
Intramolecular cyclisation of 6-phenyl-hex-2-enal
A solution of FeCl3.6H2O (0.112M in acetic anhydride, 1.2 ml, 0.134 mmol) was added
slowly dropwise to 6-phenyl-hex-2-enal (1.8 g, 10 mmol) with stirring at 5°C over 15
minutes. The reaction mixture was allowed to warm slowly to ambient temperature and
stirred for a further 20 hours. The dark mixture was poured into saturated sodium
bicarbonate solution, then extracted with ether (3x10 ml). The combined organic phase
was dried over sodium sulfate, filtered and the solvents removed in vacuo. The residue
was rapidly distilled by Kugelrohr 140-170°C at 5.0 10-2 mbar to afford the enol acetates
(2-(1,2,3,4-tetrahydro-l-naphthalenyl)vinyl acetate) as a mixture of E/Z isomers, 1.8 g.
83%.

WO 2006/120639 PCT/IB2006/051451
16
E isomer:
1H NMR: 1.68-1.70 (m, 1H), 1.71-1.80 (m, 1H), 1.86-2.01 (m, 2H)S 2.12 (s, 3H), 2.72-
2.84 (m, 2H), 3.41-3.49 (m, 1H), 5.49 (dd, J 13, 9, 1H), 7.05-7.19 (m, 5H).
13 NMR: 20.7 (q), 20.9 (t), 29.6 (t), 30.8 (t), 37.8 (d), 119.5 (d), 125.7 (d), 126.2 (d),
129.2 (d), 129.3 (d), 136.1 (d), 136.9 (s), 137.9 (s), 168.2 (s).
Z isomer:
1H NMR: 1.54-1.64 (m, 1H), 1.73-1.83 (m, 1H), 1.89-2.03 (m, 2H), 2.18 (s, 3H), 2.75-
2.86 (m, 2H), 3.99-4.06 (m, 1H), 4.98 (dd, J 10, 6, 1H), 7.05-7.14 (m, 4H), 7.16 (d, J
6,1H).
13 NMR: 20.8 (q), 21.5 (t), 29.6 (t), 30.1 (t), 34.9 (d), 118.7 (d), 125.8 (d), 126.0 (d),
128.9 (d), 129.1 (d), 133.9 (d), 136.8 (s), 138.5 (s), 168.2 (s).
Example 13
Intramolecular cyclisation of 4-methyl-6-phenyl-hex-2-enal
A solution of FeCl3.6H2O (0.112M in acetic anhydride, 1.2 ml, 0.134 mmol) was added
slowly dropwise to 4-methyl-6-phenyl-hex-2-enal (2.0 g, 10.1 mmol) with stirring at 5°C
over 15 minutes. The reaction mixture was allowed to warm slowly to ambient
temperature and stirred for a further 20 hours. The dark mixture was poured into saturated
sodium bicarbonate solution, then extracted with ether (3x10 ml). The combined organic
phase was dried over sodium sulfate, filtered and the solvents removed in vacuo. The
residue was rapidly distilled by Kugelrohr 150-180°C at 5.0 10-2 mbar to afford the enol
acetates (2-(2-methyl-1,2,3,4-tetrahydro-1-naphthalenyl)vinyl acetate) as a mixture of
isomers, 2:2:1:1, 1.9 g, 82%.
1H NMR (major isomers): 0.96 (d, J 3, 3/2H), 0.98 (d, J 2.5, 3/2 H), 1.41-1.80 (m, 2H),
1.89-2.08 (m, 1H), 2.08 (s, 3/2H), 2.19 (s, 3/2H), 2.80-2.85 (m, 2H), 3.34 (dd, J9.7,
5, 1/2H), 4.02 (dd, J 10, 5, 1/2H), 4.90 (dd, J 10.7, 6.6, 1/2H), 5.49 (dd, J 12.3, 10.2,
1/2H), 7.06-7.31 (m,5H).
13C NMR(major isomers): 18.3 (q), 18.9 (q), 20.7 (q), 20.8 (q), 26.7 (t), 26.9 (t), 28.7 (t),
28.8 (t), 32.1 (d); 32.4 (d), 116.0 (d), 117.8 (d), 125.9 (d), 126.0 (d).. 128.9 (d), 129.7
(d), 136.9 (s), 138.5 (s), 168.1 (d), 168.2 (d) ppm.

WO 2006/120639 PCT/IB2006/051451
17
Claims
1. A process for making a compound of formula

wherein the wavy line indicates that the double bond can be in a configuration E or Z or
a mixture thereof;
each R1 represents, taken separately, a hydrogen or halogen atom or a C1-C6 alkyl,
alkoxy or amino group; or the two R1, when taken together, represent a C3-C10
alkanediyl or alkenediyl group optionally substituted and optionally comprising one or
two oxygen, sulfur or nitrogen atoms;
R2 or R3 represents, taken separately, a hydrogen atom or a C1-C6 alkyl group; R2 and
R3, taken together, may represent a C3-C10 alkanediyl or alkenediyl group optionally
substituted;
R4 represents a C1-C7 alkyl or fluorinated alkyl group, a C7-C10 alkylaromatic optionally
substituted, a C1-C7 acyl group, or a -COCOOH or -COCH2COOH group; and
R5 represents a C2-C9 alkanediyl or alkenediyl group optionally substituted;
comprising the coupling of a compound of formula (II) with a compound of formula (III)

wherein R1 to R3 have the meaning indicated in formula (I) and each R6, taken
separately, represents a C1-C7 alkyl or fluorinated alkyl group, a C7-C10 alkylaromatic

WO 2006/120639 PCT/IB2006/051451
18
optionally substituted, a C1-C7 acyl group, or the R6, taken together, represent a COCO
or COCH2CO group;
or, respectively, the cyclisation of a compound of formula

wherein R1 and R3 have the meaning indicated in formula (I), R6 have the meaning
indicated in formula (III), and R5 have the meaning indicated in formula (I');
said processes being characterized in that it is carried out in the presence of a catalytic
amount of at least one catalyst selected from the group consisting of
- a salt of formula MXn, M representing a transition metal selected from the group
consisting of Fe, Co, Ni, Cu and Zn, X representing a mono-anion and n is an integer
from 1 to 3; and
- a boron compound of formula BY3, wherein Y represents a fluoride or a phenyl group
optionally substituted, and anyone of its adducts with a C2-C10 ether or a C1-C8
carboxylic acid.

2. A process according to claim 1, characterized in that the compound of
formula (II) is a benzene optionally substituted by one or two C1-C4 alkyl groups,
1,3-benzodioxole or an indane optionally substituted by one or two C1-C4 alkyl groups.
3. A process according to claim 1, characterized in that the compound of
formula (III) is acrolein diethyl acetal, acrolein diacetate, methacrolein diacetate,
crotonaldehyde diacetate, tiglyl diacetate, cyclohexenyl carbaldehyde diacetate.

WO 2006/120639 PCT/IB2006/051451
19
4 A process according to claim 1, characterized in that the catalyst is selected
from the group consisting of BY3 and adducts thereof, FeX3, CoX2, NiX2, ZnX2, CuX2
and CuX.
5. A process according to claim 4, characterized in that the catalyst is selected
from the group consisting of BY3 and its adducts, FeX3, and ZnX2.
6. A process according to claim 4, characterized in that X is a mono-anion
selected from the group consisting of acetylacetonate optionally substituted, Cl-, Br-, C1-9
carboxylate, a C1-10 sulphonate, ClO4-, BF4-, PF6-, SbCl6-, AsCl6-, SbF6-, AsF6-, BR74-,
wherein R7 is a phenyl group optionally substituted by one to five groups such as halide
atoms or methyl or CF3 groups, or a R8SO3-, wherein R8 is a chlorine or fluoride atom.
7. A process according to claim 6, characterized in that X is Cl-, Br- or
trifluoromethylsulfonate.
8. A process according to claim 4, characterized in that the catalyst is BF3 and
its adducts with AcOH, FeCl3, ZnBr2 or ZnCl2.
9. A process according to claim 1, characterized in that it further comprises
the step of generating in situ the compound of formula (III) or (IV) starting from the
corresponding enal of formula (V) or (V') respectively

wherein R1, R2, R3 and R5 have the same meaning of claim 1.

The present invention relates to the field of organic synthesis. More particularly it provides a process for making
aromatic non-conjugated enol esters or enol ethers from an aromatic compound or moiety and a protected enal compound or moiety,
such as an acetal or an acylal. The reaction is promoted by a salt of formula MX1-4, M representing a transition metal such as Zn or
Fe and X representing a mono-anion, or by BY3, wherein Y represents a fluoride or a phenyl group optionally substituted.

Documents:

03702-kolnp-2007-abstract.pdf

03702-kolnp-2007-claims.pdf

03702-kolnp-2007-correspondence others.pdf

03702-kolnp-2007-description complete.pdf

03702-kolnp-2007-form 1.pdf

03702-kolnp-2007-form 3.pdf

03702-kolnp-2007-form 5.pdf

03702-kolnp-2007-gpa.pdf

03702-kolnp-2007-international publication.pdf

03702-kolnp-2007-international search report.pdf

03702-kolnp-2007-pct priority document notification.pdf

03702-kolnp-2007-pct request form.pdf

3702-KOLNP-2007-(03-04-2012)-CORRESPONDENCE.pdf

3702-KOLNP-2007-(24-08-2012)-ABSTRACT.pdf

3702-KOLNP-2007-(24-08-2012)-AMANDED CLAIMS.pdf

3702-KOLNP-2007-(24-08-2012)-AMANDED PAGES OF SPECIFICATION.pdf

3702-KOLNP-2007-(24-08-2012)-CORRESPONDENCE.pdf

3702-KOLNP-2007-(24-08-2012)-DESCRIPTION (COMPLETE).pdf

3702-KOLNP-2007-(24-08-2012)-FORM-1.pdf

3702-KOLNP-2007-(24-08-2012)-FORM-13.pdf

3702-KOLNP-2007-(24-08-2012)-FORM-2.pdf

3702-KOLNP-2007-(24-08-2012)-OTHERS.pdf

3702-KOLNP-2007-(24-08-2012)-PETITION UNDER RULE 137.pdf

3702-KOLNP-2007-ASSIGNMENT.pdf

3702-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf

3702-KOLNP-2007-CORRESPONDENCE OTHERS 1.2.pdf

3702-KOLNP-2007-FORM 3 1.1.pdf

3702-kolnp-2007-form-18.pdf


Patent Number 254855
Indian Patent Application Number 3702/KOLNP/2007
PG Journal Number 52/2012
Publication Date 28-Dec-2012
Grant Date 27-Dec-2012
Date of Filing 01-Oct-2007
Name of Patentee FIRMENICH SA
Applicant Address 1, ROUTE DES JEUNES, P.O. BOX 239, CH-1211 GENEVA 8
Inventors:
# Inventor's Name Inventor's Address
1 SNOWDEN ROGER 512, MONTEE DU FORT, LE FORT, F-74580 VIRY
2 WOMACK GARY 23 BRANDON ROAD, HOPEWELL, NEW JERSEY 08648
3 BIRKBECK ANTHONY QUAI DES ARENIERES 10, CH-1205 GENEVA
PCT International Classification Number C07C 67/293
PCT International Application Number PCT/IB2006/051451
PCT International Filing date 2006-05-09
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 PCT/IB2005/001310 2005-05-11 IB